TransEnterix Inc. (TRXC) Plunges 5.11% on March 19

TransEnterix Inc. (TRXC) Plunges 5.11% on March 19

TransEnterix Inc. (TRXC) had a rough trading day for Tuesday March 19 as shares tumbled 5.11%, or a loss of $-0.12 per share, to close at $2.23. After opening the day at $2.28, shares of TransEnterix Inc. traded as high as $2.34 and as low as $2.21. Volume was 2.64 million shares over 5,358 trades, against an average daily volume of 3.22 million shares and a total float of 217.01 million.

As a result of the decline, TransEnterix Inc. now has a market cap of $483.94 million. In the last year, shares of TransEnterix Inc. have traded between a range of $6.98 and $1.58, and its 50-day SMA is currently $2.65 and 200-day SMA is $3.87.

TransEnterix Inc is a medical device company engaged in the development and commercialization of a robotic-assisted surgical system. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the single-port robotically enhanced the laparoscopic surgical platform.

TransEnterix Inc. is based out of Morrisville, NC and has some 189 employees. Its CEO is Todd M. Pope.

Share:
error: Content is protected !!